Possible role for interactions between 5-lipoxygenase (5-LOX) and AMPA GluR1 receptors in depression and in antidepressant therapy
- 1 January 2007
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 69 (5) , 1076-1079
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The 5-lipoxygenase enzymatic pathway in the mouse brain: Young versus oldNeurobiology of Aging, 2007
- Regulatory mechanisms of AMPA receptors in synaptic plasticityNature Reviews Neuroscience, 2007
- Negative Emotions and 3-Year Progression of Subclinical AtherosclerosisArchives of General Psychiatry, 2007
- Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugsBiochemical and Biophysical Research Communications, 2007
- Genome Wide Gene Expression Studies in Mood DisordersOMICS: A Journal of Integrative Biology, 2006
- Binding Investigation of Human 5-Lipoxygenase with Its Inhibitors by SPR Technology Correlating with Molecular Docking SimulationThe Journal of Biochemistry, 2006
- Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatmentNeuropharmacology, 2005
- AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A2and 5-lipoxygenase activitiesHippocampus, 2005
- Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampusHippocampus, 1998
- Glutamate receptor phosphorylation and synaptic plasticityCurrent Opinion in Neurobiology, 1994